{{drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 416898838
| IUPAC_name = 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-''N,N''-dimethyl-2,2-diphenylbutanamide
| image = Loperamide.svg
| width = 250
| image2 = Loperamide 3D ball.png
| width2 = 235
<!--Clinical data-->
| pronounce = {{IPAc-en|l|oʊ|ˈ|p|ɛr|ə|m|aɪ|d}}
| tradename = Imodium, others<ref name=Names>Drugs.com [http://www.drugs.com/international/loperamide.html International brands for loperamide] {{Wayback|url=http://www.drugs.com/international/loperamide.html |date=20170909005921 }} Page accessed Sept 4, 2015</ref>
| Drugs.com = {{drugs.com|monograph|loperamide-hydrochloride}}
| MedlinePlus = a682280
| pregnancy_AU = B3 
| pregnancy_US = C
| legal_AU = S2
| legal_CA = OTC
| legal_UK = GSL
| legal_US = OTC
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability = 0.3%
| protein_bound = 97%
| metabolism = [[Liver|Liver]] (extensive)
| elimination_half-life = 9–14 hours<ref name=AHFS2015/>
| excretion = Faeces (30–40%), urine (1%)
<!--Identifiers-->
| IUPHAR_ligand = 7215
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 53179-11-6
| CAS_number2 = 34552-83-5
| CAS_number2_comment = with HCl
| ATC_prefix = A07
| ATC_suffix = DA03
| ATC_supplemental = <br />{{ATC|A07|DA05}} (oxide)
| PubChem = 3955
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00836
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3818
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6X9OC3H4II
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08144
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 6532
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 841
| synonyms = R-18553
<!--Chemical data-->
| C=29 | H=33 | Cl=1 | N=2 | O=2
| molecular_weight = 477.037 g/mol (513.506 with HCl)
| SMILES = ClC1=CC=C(C2(CCN(CC2)CCC(C3=CC=CC=C3)(C(N(C)C)=O)C4=CC=CC=C4)O)C=C1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RDOIQAHITMMDAJ-UHFFFAOYSA-N
}}
'''洛哌丁胺'''（{{Lang|en|loperamide}}）, 較常用的商品名是'''Imodium'''，是一種止[[腹瀉|腹瀉]]藥物<ref name=":1">{{Cite web|url=http://www.drugs.com/international/loperamide.html|title=International brands for loperamide|accessdate=2015-09-04|author=Drugs.com|date=|publisher=|archive-date=2017-09-09|archive-url=https://web.archive.org/web/20170909005921/https://www.drugs.com/international/loperamide.html|dead-url=no}}</ref>。常用於[[腸胃炎|腸胃炎]]、[[炎症性肠病|炎症性肠病]]、和短腸徵候群。洛哌丁胺並不適用於[[痢疾|痢疾]]病人身上，大多是口服藥物<ref name=":0">{{Cite web|url=http://www.drugs.com/monograph/loperamide-hydrochloride.html|title=Loperamide Hydrochloride|accessdate=Aug 25, 2015|author=|date=|publisher=The American Society of Health-System Pharmacists|archive-date=2018-11-01|archive-url=https://web.archive.org/web/20181101070913/https://www.drugs.com/monograph/loperamide-hydrochloride.html|dead-url=no}}</ref>。

==副作用 ==
常見的副作用包括腹痛、[[便秘|便秘]]、嗜睡、[[呕吐|呕吐]]和[[口乾|口乾]]舌燥。藥物會增加罹患毒性巨結腸症的風險<ref name=":1" />。洛哌丁胺還尚未確定，是否能安全使用於[[妊娠|妊娠]]婦女，但目前並未有特定的毒性報告<ref name=":1" />。目前認為即便是[[母乳餵養|餵養母乳]]者使用都相對安全<ref name=":1" />。洛哌丁胺是一種不被吸收且不穿過[[血腦屏障|血腦屏障]]的[[鴉片類藥物|鴉片類藥物]] 。洛哌丁胺的作用原理是減緩小腸蠕動，減緩腹瀉的症狀<ref name=":0" />。

== 歷史、社會、與文化==
洛哌丁胺於1969年被合成，1976年被作為藥物使用<ref name=":1" />。洛哌丁胺也被列在[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]上，是每個照護系統最該具備的藥物之一<ref name=":1" />。洛哌丁胺也是相當平價的[[通用名药物|通用名药物]]<ref name="AHFS2015">{{cite web|url=http://www.drugs.com/monograph/loperamide-hydrochloride.html|title=Loperamide Hydrochloride|accessdate=Aug 25, 2015|publisher=The American Society of Health-System Pharmacists|archive-date=2018-11-01|archive-url=https://web.archive.org/web/20181101070913/https://www.drugs.com/monograph/loperamide-hydrochloride.html|dead-url=no}}</ref><ref name=":0" />。洛哌丁胺每劑批發價介於0.004到0.04美元之間<ref>{{Cite web|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=LOP2T&s_year=2014&year=2014&str=2%20mg&desc=Loperamide%20HCl&pack=new&frm=TAB-CAP&rte=PO&class_code2=17%2E&supplement=&class_name=%2802%2E3%2E%29Medicines%20for%20other%20common%20symptoms%20in%20palliative%20care%3Cbr%3E%2817%2E%29Gastrointestinal%20medicines%3Cbr%3E|title=Loperamide HCL|accessdate=26 August 2015|author=International Drug Price Indicator Guide|date=|publisher=|deadurl=yes|archiveurl=https://web.archive.org/web/20170510095624/http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=LOP2T&s_year=2014&year=2014&str=2%20mg&desc=Loperamide%20HCl&pack=new&frm=TAB-CAP&rte=PO&class_code2=17.&supplement=&class_name=%2802.3.%29Medicines%20for%20other%20common%20symptoms%20in%20palliative%20care%3Cbr%3E%2817.%29Gastrointestinal%20medicines%3Cbr%3E|archivedate=2017年5月10日}}</ref>。在美國的市價大約每劑是0.2[[美元|美元]]<ref>{{Cite web|url=https://data.medicaid.gov/Drug-Prices/NADAC-National-Average-Drug-Acquisition-Cost-/a4y5-998d|title=Loperamide|accessdate=16 April 2016|author=NADAC (National Average Drug Acquisition Cost) Centers for Medicare and Medicaid Services.|date=|publisher=|archive-date=2017-01-18|archive-url=https://web.archive.org/web/20170118223239/https://data.medicaid.gov/Drug-Prices/NADAC-National-Average-Drug-Acquisition-Cost-/a4y5-998d|dead-url=yes}}</ref>。

==參考文獻==
{{Reflist|30em}}

==外部連結==
* [http://imodium.com/ Imodium website] {{Wayback|url=http://imodium.com/ |date=20210419192516 }}

{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}

[[Category:醇|Category:醇]]
[[Category:止泻药|Category:止泻药]]
[[Category:比利時發明|Category:比利時發明]]
[[Category:氯代芳烴|Category:氯代芳烴]]
[[Category:楊森製藥|Category:楊森製藥]]
[[Category:哌啶|Category:哌啶]]
[[Category:合成阿片样物质|Category:合成阿片样物质]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]